"DOV’s 3.5 percent worldwide royalty on the drug’s sales would probably amount to much less than the $350 million in annual revenues it would have received on billion-dollar sales,"
3.5% if 1B is $350M? Uhm...I learned something new in here.
No real news from the article, weird that someone keeps buying though...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.